Residual Platelet Activity In Advanced Peripheral Artery Disease
Status:
Unknown status
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The peripheral arterial disease (PAD) is a common atherosclerotic disease manifestation and
its prevalence increase with age and with the simultaneous presence of cardiovascular risk
factors.
PAD patients are usually treated, as a first line treatment, with the exercise therapy,
combined with the pharmacological antiplatelet therapy.
In the case of first line therapy failure, PAD patients usually undergoing to invasive
revascularization procedures.
After a peripheral stent has been located, the major follow-up problem is the restenosis
rate.
Published studies describe how, in a large amount of patients, can be recognised an high
residual platelet activity. These data about PAD patients at the moment are lacking .
The authors would evaluate the incidence of PAD patients with an high residual platelet
activity.